Bacterial Vaginosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Bacterial Vaginosis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Vaginosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Vaginosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial Vaginosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific... Research Beam Model: Research Beam Product ID: 153547 2500 USD New
Bacterial Vaginosis Global Clinical Trials Review, H2, 2014

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Bacterial Vaginosis Global Clinical Trials Review, H2, 2014

 
  • Category : Pharmaceuticals
  • Published On : November  2014
  • Pages : 77
 
 
Bacterial Vaginosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Bacterial Vaginosis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Vaginosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Vaginosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial Vaginosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bacterial Vaginosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bacterial Vaginosis 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Bacterial Vaginosis Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Bacterial Vaginosis 33
Sep 09, 2014: Symbiomix Therapeutics Makes First Corporate Announcement: Completion of Enrollment in a Phase 2 Clinical Trial of SYM-1219 for Bacterial Vaginosis 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Starpharma Holdings Limited 34
Clinical Trial Overview of Starpharma Holdings Limited 34
Symbiomix Therapeutics, LLC 35
Clinical Trial Overview of Symbiomix Therapeutics, LLC 35
Merck & Co., Inc. 36
Clinical Trial Overview of Merck & Co., Inc. 36
Ferring International Center S.A. 37
Clinical Trial Overview of Ferring International Center S.A. 37
AmVac AG 38
Clinical Trial Overview of AmVac AG 38
Osel Inc. 39
Clinical Trial Overview of Osel Inc. 39
Mission Pharmacal Company 40
Clinical Trial Overview of Mission Pharmacal Company 40
Actavis plc 41
Clinical Trial Overview of Actavis plc 41
Arun Pharmaceuticals Limited 42
Clinical Trial Overview of Arun Pharmaceuticals Limited 42
Alfa Wassermann S.p.A 43
Clinical Trial Overview of Alfa Wassermann S.p.A 43
Clinical Trial Overview of Top Institutes / Government 44
University of Alabama at Birmingham 44
Clinical Trial Overview of University of Alabama at Birmingham 44
University of Pittsburgh 45
Clinical Trial Overview of University of Pittsburgh 45
Shiraz University of Medical Sciences 46
Clinical Trial Overview of Shiraz University of Medical Sciences 46
Lawson Health Research Institute 47
Clinical Trial Overview of Lawson Health Research Institute 47
Centers for Disease Control and Prevention 48
Clinical Trial Overview of Centers for Disease Control and Prevention 48
Eunice Kennedy Shriver National Institute of Child Health and Human Development 49
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 49
Mount Sinai Hospital 50
Clinical Trial Overview of Mount Sinai Hospital 50
The National Institute of Allergy and Infectious Diseases 51
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 51
Ahvaz Jundishapur University of Medical Sciences 52
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 52
Five Key Clinical Profiles 53
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77
List Of Tables
List of Tables
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bacterial Vaginosis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Bacterial Vaginosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Bacterial Vaginosis Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Starpharma Holdings Limited, 2014* 34
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Symbiomix Therapeutics, LLC, 2014* 35
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 36
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2014* 37
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AmVac AG, 2014* 38
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Osel Inc., 2014* 39
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mission Pharmacal Company, 2014* 40
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 41
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arun Pharmaceuticals Limited, 2014* 42
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfa Wassermann S.p.A, 2014* 43
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014* 44
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 45
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014* 46
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2014* 47
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014* 48
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 49
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai Hospital, 2014* 50
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 51
Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014* 52
List Of Figures
List of Figures
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 76